AUROBINDO PHARMA at All Time High; BSE HEALTHCARE Index Up 1.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA at All Time High; BSE HEALTHCARE Index Up 1.0%
Mon, 25 Jan 12:55 PM

AUROBINDO PHARMA share price has hit an all-time high at Rs 1,012 (up 9.4%).

Meanwhile, the BSE HEALTHCARE Index is at 21,558 (up 1.0%).

Among the top gainers in the BSE HEALTHCARE Index today are AUROBINDO PHARMA (up 9.4%) and ABBOTT INDIA (up 0.8%).

THYROCARE TECHNOLOGIES (down 0.1%) and LAURUS LABS (down 0.2%) are among the top losers today.

Over the last one year, AUROBINDO PHARMA has moved up from Rs 493 to Rs 1,012, registering a gain of Rs 519 (up 104.9%).

The BSE HEALTHCARE has moved up from 14,005 to 21,558, registering a gain of 7,553 points (up 53.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were LAURUS LABS (up 358.0%), GRANULES INDIA (up 144.6%) and STRIDES PHARMA SCIENCE (up 119.7%).

Free Signup: The Smallcap Fortunes Summit

What About the Benchmark Indices?

The BSE Sensex is at 49,263 (down 0.1%). The top gainers among the BSE Sensex stocks today are AXIS BANK (up 3.4%), SUN PHARMA (up 2.4%) and BAJAJ FINSERV (up 1.8%). Other gainers include TATA STEEL (up 1.8%) and HDFC BANK (up 1.6%). The most traded stocks in the BSE Sensex are TATA STEEL and ICICI BANK.

In the meantime, NSE Nifty is at 14,491 (down 0.1%). The top gainers in the NSE Nifty include GRASIM (up 9.3%), CIPLA (up 4.3%) and UPL (up 4.2%). Other gainers include AXIS BANK (up 3.1%) and JSW STEEL (up 2.2%).

Over the last 12 months, the BSE Sensex has moved up from 41,324 to 49,263, registering a gain of 7,939 points (up 18.2%).

AUROBINDO PHARMA Financial Update...

AUROBINDO PHARMA net profit stood at Rs 8 billion for the quarter ended June 2020, compared to a profit of Rs 7 billion a year ago. Net Sales rose 2.2% to Rs 59.2 billion during the period as against Rs 58.0 billion in April-June 2019.

For the year ended March 2019, AUROBINDO PHARMA reported 1.2% increase in net profit to Rs 24.5 billion compared to net profit of Rs 24.2 billion during FY18.

Revenue of the company grew 18.6% to Rs 196 billion during FY19.

The current Price to earnings ratio of AUROBINDO PHARMA, based on rolling 12 month earnings, stands at 19.7x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA at All Time High; BSE HEALTHCARE Index Up 1.0%". Click here!

  

Stock Market Updates

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally (Today's Market)

Mar 2, 2021 Closing

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

GUJ. STATE PETRONET Share Price Up by 5%; BSE 500 Index Up 1.4% (Today's Market)

Mar 2, 2021 03:31 PM

GUJ. STATE PETRONET share price is trading up by 5% and its current market price is Rs 262. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are GUJ. STATE PETRONET (up 5.2%) and GSK CONSUMER (up 5.1%). The top losers are BAYER CROPSCIENCE and LAURUS LABS.

GUJARAT PIPAVAV PORT Share Price Up by 12%; BSE REALTY Index Up 0.8% (Today's Market)

Mar 2, 2021 03:23 PM

GUJARAT PIPAVAV PORT share price is trading up by 12% and its current market price is Rs 114. The BSE REALTY is up by 0.8%. The top gainers in the BSE REALTY Index is GUJARAT PIPAVAV PORT (up 12.5%). The top losers are PRESTIGE ESTATES and PHOENIX MILL (down 0.2%).

STRIDES PHARMA SCIENCE Share Price Up by 5%; BSE HEALTHCARE Index Up 1.1% (Today's Market)

Mar 2, 2021 03:23 PM

STRIDES PHARMA SCIENCE share price is trading up by 5% and its current market price is Rs 878. The BSE HEALTHCARE is up by 1.1%. The top gainers in the BSE HEALTHCARE Index is STRIDES PHARMA SCIENCE (up 5.1%). The top losers are AJANTA PHARMA (down 0.4%) and CAPLIN POINT (down 0.4%).

JAGRAN PRAKASHAN Share Price Down by 7%; BSE 500 Index Up 1.3% (Today's Market)

Mar 2, 2021 03:23 PM

JAGRAN PRAKASHAN share price is trading down by 7% and its current market price is Rs 63. The BSE 500 is up by 1.3%. The top gainers in the BSE 500 Index are SYMPHONY (up 20.0%) and SHIPPING CORP (up 20.0%). The top losers is JAGRAN PRAKASHAN (down 7.4%)..

JK LAKSHMI CEMENT Share Price Up by 11%; BSE 500 Index Up 1.0% (Today's Market)

Mar 2, 2021 03:15 PM

JK LAKSHMI CEMENT share price is trading up by 11% and its current market price is Rs 438. The BSE 500 is up by 1.0%. The top gainers in the BSE 500 Index are JK LAKSHMI CEMENT (up 11.0%) and TTK PRESTIGE (up 11.1%). The top losers are CROMPTON GREAVES CONSUMER ELEC. and RAYMOND .

View More Indian Share Market News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

S&P BSE SENSEX


Mar 2, 2021 (Close)

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
  • Follow on YouTube
  • Follow on LinkedIn Follow @Equitymaster Follow on RSS Follow on Telegram

APP
  • Get Equitymaster Android App on Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.